GNAI3

Chr 1

G protein subunit alpha i3

Also known as: 87U6, ARCND1, ARCODS, HG1A

Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in various transmembrane signaling pathways. G proteins are composed of 3 units: alpha, beta and gamma. This gene encodes an alpha subunit and belongs to the G-alpha family. Mutation in this gene, resulting in a gly40-to-arg substitution, is associated with auriculocondylar syndrome, and shown to affect downstream targets in the G protein-coupled endothelin receptor pathway. [provided by RefSeq, Jun 2012]

ResearchGenerating clinical summary…
MultiplemechanismLOEUF 0.61
Clinical SummaryGNAI3
🧬
Gene-Disease Validity (ClinGen)
auriculocondylar syndrome · ADModerate

Moderate evidence — consider for supplementary testing

Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.31) despite low pLI — interpret in context.
📋
ClinVar Variants
5 unique Pathogenic / Likely Pathogenic· 50 VUS of 92 total submissions
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.61LOEUF
pLI 0.038
Z-score 2.82
OE 0.31 (0.170.61)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
1.79Z-score
OE missense 0.64 (0.550.74)
122 obs / 191.8 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.31 (0.170.61)
00.351.4
Missense OE?0.64 (0.550.74)
00.61.4
Synonymous OE?0.95
01.21.6
LoF obs/exp: 6 / 19.4Missense obs/exp: 122 / 191.8Syn Z: 0.33
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveGNAI3-related auriculocondylar syndromeOTHERAD

This gene — mechanism propensity

DN
0.6551th %ile
GOF
0.6833th %ile
LOF
0.2969th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). The Badonyi & Marsh model scores gain-of-function highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports dominant-negative. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median · 1 literature citation
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

DNNovel variants in GNAI3 associated with auriculocondylar syndrome strengthen a common dominant negative effect.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

References

  1. 1.PMID 25026904

ClinVar Variant Classifications

92 submitted variants in ClinVar

Classification Summary

Pathogenic1
Likely Pathogenic4
VUS50
Likely Benign16
Benign8
1
Pathogenic
4
Likely Pathogenic
50
VUS
16
Likely Benign
8
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
1
0
0
0
1
Likely Pathogenic
1
3
0
0
4
VUS
1
48
1
0
50
Likely Benign
0
2
3
11
16
Benign
0
0
6
2
8
Total353101379

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

4 pathogenic / likely-pathogenic (of 8) ClinVar copy-number / structural variants overlap GNAI3 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

GNAI3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →